Episode Overview

Why Global Sponsors Keep Coming Back to India

Why do some global sponsors return to India for their second, third or even fourth clinical study?

The answer may have less to do with cost than many assume.

In this episode, Kriti and Mark explore the factors that can make India a valuable environment for clinical research — including access to relevant participant populations, recruitment capabilities, physician-patient relationships, clinical research infrastructure and experience across health categories.

The discussion also addresses a question global sponsors frequently face:

If a product is ultimately sold in the United States, Europe or other international markets, can clinical research conducted in India generate relevant evidence?

Rather than treating geography as the deciding factor, the conversation focuses on relevance, representation and fitness for purpose.

The episode also explores why recruitment speed can have a direct commercial impact. Faster recruitment can potentially shorten the time between study initiation and the availability of evidence that supports subsequent product, regulatory, marketing and commercial decisions.

For nutraceutical and consumer health companies, the conversation becomes particularly relevant across areas such as metabolic health, gut health, women's health, healthy ageing and botanicals.

Ultimately, Episode 2 asks sponsors to look beyond the question of where a clinical trial is conducted and focus on whether the research environment gives the study the best opportunity to generate meaningful, credible evidence.